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INTRODUCTION 
Immediate contact skin reactions manifest as Contact Urticaria (CoU), Contact Urticaria Syndrome 
(CUS) and Protein Contact Dermatitis (PCD). These pathologies are characterized by the immediate 
skin development of itchy flares, wheals and/or dermatitis, following external contact with a substance 
(1). 
 CoU usually appears within 30 minutes, and clears completely within hours, without residual signs 
of irritation. Fisher defined it in 1973, even if this phenomenon had been recognized for many years 
(2). CoU is a very frequent pathology, and an ever-expanding list of causes, substances ranging from 
simple chemicals to macromolecules, has been reported. Mostly proteins (molecular weight 10000 Da 
to several hundred thousands), but also chemical compounds of low molecular weight (LMW) (< 1000 
Da) are involved. The present chapter will focus mainly on these chemical compounds of LMW. 
 In order to review the LMW chemical agents responsible for immediate contact skin symptoms, it 
is first necessary to remind the defined categories of CoU according to the underlying mechanism(s) 
involved. Basically, CoU is classified as non-immunological or immunological. A third category exists 
for reactions with mixed features or undetermined pathomechanisms (3). Non-immunological CoU 
(NICoU) is the most common form of the disease, occurring without prior exposure to an eliciting 
substance, that means without previous sensitization. Substances inducing NICoU are frequently 
encountered in our environment as preservatives, fragrances and flavorings in cosmetics, toiletries, 
topical medicaments and foodstuffs (4, 5). The pathogenesis is not clearly understood but it appears to 
involve the release of vasogenic mediators without involvement of immunological processes. Due to 
the lack of response to antihistamines and the positive response to acetylsalicylic acid and non-steroidal 
anti-inflammatory drugs, it has been proposed that the physiopathology involves prostaglandin release 
from the epidermis rather than histamine release from the mast cells, as previously assumed (6, 7). On 
the other hand, immunologic CoU (ICoU) is a type I hypersensitivity reaction, mediated by allergen-
specific immunoglobulin E (IgE) in previously sensitized individuals (3). In this case, the release of 
histamine is the major mechanism of action seen. The mechanism following skin challenge includes 
allergen penetration through the epidermis, binding to IgE on mast cells, causing degranulation and 
release of histamine and other vasoactive substances such as prostaglandins, leukotrienes and kinins 
(8). Again, a large number of causes have been documented as causing ICoU. Many are plant or animal 
proteins (9). However, many LMW chemicals including drugs, biocides and preservatives, metals or 
industrial compounds can also produce ICoU. Finally, a third category exists for substances that show 
mixed features of NICoU and ICoU, or where the mechanism remains unclear. The bleaching agent 
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ammonium persulfate is a classic example. Although the clinical picture looks like an IgE-mediated 
reaction, such antibodies against ammonium persulfate have not been identified (5, 10). However, this 
third category is much less common and will not be treated herein. 
 Tables 1 and 2 resume the most reported LMW chemical agents producing immediate non-
immunologic and immunologic skin reactions (1, 11). 
 
CHEMICALS AND NON-IMMUNOLOGICAL REACTIONS 
Chemical compounds mainly described as triggering immediate contact reactions and NICoU are listed 
in Table 1. Many of these chemicals are used in fragrances, in cosmetic products, as biocides or 
preservatives, and as drugs or topical medications. Though, there are also other miscellaneous 
chemicals and metals responsible for these reactions. Most individuals react to these substances with 
local erythema and/or edema within 45 min after application, albeit with widely varying intensities of 
skin reaction (12). 
 
Fragrances and cosmetics ingredients 
NICoU reactions to fragrances and to cosmetics ingredients are well known (13). NICoU has been 
reported for example to some of the constituents of the Fragrance Mix I (FMI), and to balsam of Peru 
(14). However, clinical relevance must be carefully examined because individuals may develop simple 
NICoU or contact urticaria associated with delayed hypersensitivity. Indeed, the components of the 
FMI (α-amyl cinnamic aldehyde, cinnamic aldehyde, cinnamic alcohol, eugenol, isoeugenol, geraniol, 
hydroxycitronellal, oak moss) are potent skin sensitizers responsible for delayed type allergic contact 
dermatitis. Actually, the FMI, developed in the late 1970s, and the Fragrance Mix II developed in 2005, 
are the most valuable screening tools for the detection of delayed hypersensitivity to fragrances (15, 
16). Safford et al. conducted a study on 20 patients positive to the FMI in 48 hours and classified the 
FMI ingredients according to the decreasing ability to induce contact urticaria as follows: cinnamic 
aldehyde, cinnamic alcohol, isoeugenol, hydroxycitronellal and geraniol (17). Cinnamic aldehyde and 
cinnamic alcohol were the strongest urticaria inducers for non-allergic patients. Contact urticaria from 
cinnamic aldehyde has been reported by several authors (4), leading even to anaphylaxis (18). Among 
the many components of balsam of Peru, cinnamic aldehyde is described as well as the strongest agent 
inducing NICoU, followed by cinnamic acid, benzoic acid and benzaldehyde (19). Cinnamic aldehyde 
is the main component of cassia oil (ca. 90%) and cinnamon bark oil (ca. 75%). It is also the main 
component of artificial cinnamon oil. Smaller quantities are found in many other essential oils. In 
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nature, the trans isomer is predominant. It is a yellowish liquid with a characteristic spicy odor, 
strongly reminiscent of cinnamon. Being an α,β-unsaturated aldehyde, it undergoes many reactions of 
which hydrogenation to cinnamic alcohol. Its oxidation occurs readily on exposure to air yielding 
cinnamic acid. Cinnamic acid has been also used in perfumery, as a flavoring ingredient in 
pharmaceutical preparations and in food products. Forsbeck and Skog found contact urticaria from 
cinnamic acid 5% in petrolatum in three out of five patients with immediate skin reactions to balsam of 
Peru (19). The unsaturated terpene alcohol geraniol, a colorless liquid with a flowery-rose like odor, 
gave a patch test reaction after 20 min of application in a woman suffering from recurring oedema in 
the lips and neck. The test with a perfume containing geraniol gave generalized urticaria (20). CUS at 
stage IV has been reported in the case of people applying sunscreen and self-tanning products, being 
benzophenone-3 the major cause (21). Benzophenone-3, also named oxybenzone, is often incorporated 
into sunscreen formulations to offer enhanced UVA protection because its absorption spectrum extends 
to less than 350 nm. In toothpaste and in a make-up remover, menthol, belonging to the family of 
monoterpenols, was described as the reason for urticaria reactions, plus cephalgia, in a woman placed 
in a context of generalized urticaria (22). Symptoms disappeared with total eviction of menthol. 
 
Biocides and preservatives 
Many compounds used as preservatives, such as imidazolidinyl urea, bronopol and sorbic acid, have 
been shown to induce positive reactions at patch test after 45 min in a population of 50 patients (23). 
Contact urticaria from sorbic acid is however thought to be rare, and only few reports can be found in 
the literature. Some authors described that creams and shampoos containing sorbic acid caused 
erythema, slight itching and oedema sometimes (24, 25). Like sorbic acid, benzoic acid is a natural 
preservative, having antibacterial and antifungal properties. Present also in balsam of Peru, it induced 
contact urticaria at 5% in patients with immediate contact reactions to balsam of Peru (19). It has also 
been commonly used as a preservative in acidic food products. Thus, it was reported in a published 
study that benzoic and sorbic acid could elicit NICoU at concentrations in use in salad dressing in 18 of 
20 school children (26). In the case of free formaldehyde, for which bactericidal and fungicidal 
properties confer it a place of choice for preservation of cosmetics, its use has been reduced because of 
the bad press it has received as an irritant, sensitizer and potential carcinogen (27). Formaldehyde is 
known to be a strong-ubiquitous skin sensitizer, including from non-cosmetic sources of contact. 
Because of this, exposure to formaldehyde in the EU is subject to restrictions. Free formaldehyde may 
be used as a preservative in all cosmetic products (maximum authorized concentration 0.2%, except 
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0.1% in products for oral hygiene) except aerosol cosmetics. Annex VI of the Cosmetics Directive 
76/768 EC further stipulates that all finished products containing formaldehyde or substances that 
release formaldehyde must be labelled with the warning “contains formaldehyde” where the 
concentration of free formaldehyde in the finished product exceeds 0.05% (28). As an alternative, 
chemical compounds that slowly release formaldehyde in the presence of water and under usage 
conditions, the so-called formaldehyde-releasers, are commonly employed as preservatives in 
cosmetics (water based preparations) instead of free formaldehyde. Examples are bronopol and 
imidazolidinyl urea. Unfortunately, many formaldehyde-releasers used in cosmetics are also skin 
sensitizers, due to released formaldehyde but also to reactive intermediates other than formaldehyde 
that could be involved in the formation of the hapten-protein antigenic complex, a key step of the 
sensitization process, and thus explaining their sensitizing potential per se (29). Even if it is a strong 
sensitizer, reported immediate reactions to formaldehyde are mainly classified as NICoU because they 
seem not to be mediated by IgE  (30).  However, there is still no consensus in the reports that have 
appeared as to whether the mechanism is immunological or non-immunological (31). Contact urticaria 
to other biocides such as p-chloro-m-cresol, benzyl alcohol, 2-phenoxyethanol and polyethylene 
glycols, used as preservatives in a wide number of cosmetics and topical preparations, has also been 
reported (32-35). Contact urticaria from alcohols was reviewed in the 90s, with cases classified as non-
immunological and some as immunological based on open skin tests (36). 
 
Drugs 
Many drugs can also provoke immediate skin reactions. They include mainly antibiotics, because direct 
contact of nurses and health care personnel during their preparation, or employees during the 
production in the pharmaceutical industry. Penicillins and cephalosporins are the most incriminated. 
All of them seem to have an immunological physiopathology and will be discussed below. For most of 
the other drugs reported, observed immediate contact reactions cannot be definitely classified as non-
immunological or immunological. Often, skin tests do not allow distinguishing between an IgE 
dependent reaction and a non-specific histamine release, and research of specific IgE by using the 
radioallergosorbent test (RAST) is only available for some drugs. One example is given by lidocaine. It 
is a common amino amide-type local anaesthetic applied topically, and the most important class 1B 
antiarrhythmic drug applied intravenously. An immediate positive patch test and prick test 
demonstrated its involvement in the simultaneous presence of contact urticaria and allergic contact 
dermatitis in the same patient (37, 38). Ketoprofen, an important cause of photocontact dermatitis, has 
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also been described as responsible for contact urticaria (39). Other immediate reactions have been 
observed in personnel of psychiatry services during the manipulation of phenothiazines, antipsychotic 
drug related to the thiazine class of heterocyclic compounds, such as chlorpromazine and promethazine 
(40). 
 
To end with this section, among the many professional areas where case reports of contact urticaria 
have been reported, workers of pharmaceutical and chemical industries are of considerable concern. 
They are in contact with highly reactive substances (some listed in Table 1) used for synthesis for 
example that have been also described as inducers of immediate skin reactions. 
The pathogenesis of NICoU to all these chemicals is not clearly defined. Different urticariogens 
may act by different mechanisms. For example, dimethyl sulfoxide can both damage blood vessels and 
cause mast cell degranulation. However, antihistamines do not inhibit reactions to dimethyl sulfoxide 
and other NICoU triggering agents, whilst acetylsalicylic acid and non-steroidal anti-inflammatory 
drugs do, both orally and topically, suggesting a role for prostaglandins (6, 7, 41). Release of 
prostaglandin D2 without concomitant histamine release has been shown for instance following topical 
application of sorbic acid and benzoic acid (42, 43).  
 
CHEMICALS AND IMMUNOLOGICAL REACTIONS 
ICoU is an immediate type 1 hypersensitivity reaction, occurring in patients who have specific IgE 
against the agent(s) eliciting contact urticaria. ICoU needs sensitization, and will appear after repeated 
contacts. It is more frequent in people with previous atopic symptoms. The allergen reacts with the IgE 
at the surface of mast cells and basophiles and provokes the release of histamine and other vasoactive 
substances, except in rare cases where IgG or IgM have been incriminated. The consequences are 
potentially more serious than for NICoU, as reactions may not remain localized to the area of contact, 
and generalized urticaria, or even involvement of organs such as the respiratory and gastrointestinal 
tract may follow, and end with anaphylactic shock. The commonest agents inducing ICoU are food 
proteins (animal or vegetal), animal proteins, and natural rubber latex, and have been largely reviewed 
(9, 44). However, chemicals of LMW can also induce ICoU and are listed in Table 2. They are very 
often present in drugs, cosmetics (45) and industrial preparations. There are extensive lists of proteins 
and chemicals reported as causing ICoU, only a part of them being reported as occupational (3, 11, 44). 
Most publications about contact urticaria concern case reports or little series and epidemiological 
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studies are scarce. However, some data indicate that ICoU is not rare, although frequently 
underestimated. 
 Diagnosis of occupational contact urticaria is based on the patient’s previous medical history, 
chronology and description of skin symptoms. With exception to substances inducing NICoU, skin 
tests are generally necessary for diagnosis. An order of skin investigations for evaluation of immediate 
responses has been suggested (3, 46). Skin prick tests with fresh material or commercial reagents is the 
gold standard diagnostic test (8). But the ultimate evidence corroborating that a compound is 
responsible for ICoU is the measurement of specific IgE in the serum of the patient by the 
radioallergosorbent RAST test whenever possible. The RAST is a radioimmunoassay test to detect 
specific IgE antibodies to a suspected or known agent (protein, chemical compound) responsible of 
ICoU. The patient’s serum is incubated with the agent bound to a solid phase, and the amount of 
specific IgE recognising and binding to the agent is quantified with radiolabelled anti-IgE (47). 
Determination of specific IgE by RAST will confirm type I hypersensitivity, but their ordinary 
detection is restricted to some compounds, particularly when they are non-proteinaceous. In this 
section, some examples reported in the literature are given. 
 
Evidence on IgE-mediated urticaria to low molecular weight compounds: reported examples 
Biocides and preservatives 
Chloramine is commonly used as a sterilizer, disinfectant and chemical reagent. It has been described 
as an occupational hazard for pharmaceutical workers, nurses and cleaners. Goossens et al. reported the 
first case of immediate positive epicutaneous tests to chloramine powder solutions used by a nurse (48). 
All skin tests performed on the patient were suspicious of an immediate type reaction. The 
immunological nature of the clinical manifestations was investigated by RAST on serum of the patient. 
High levels of IgE antibodies to chloramine were found, those previously bound to human serum 
albumin (HSA). The clinical manifestation on the patient was confirmed by radioimmunoassay and 
classified as a stage 3 contact urticaria syndrome. Chloramine is often confused with chloramine-T as 
both are employed as sterilizer, antiseptic and disinfectant agents. However, they are two different 
chemicals. Chloramine-T is a N-chlorinated deprotonated sulfonamide, white powder, contrarily to 
chloramine, a simple monochlorinated amine (NH2Cl) which is a colorless liquid usually handled as a 
diluted aqueous solution. Allergic asthma caused by chloramine-T is well known and the reactions are 
IgE mediated. Kramps et al. were able to demonstrate the presence of specific IgE antibodies in the 
serum of asthmatic-chloramine T allergic patients (49). However, skin symptoms of IgE dependent 
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contact urticaria have also been reported in the case of a hospital bath attendant in Finland. The 
performed RAST to chloramine-T showed specific IgE antibodies with values being defined as positive 
(50). 
 Chlorhexidine, a cationic chlorophenyl-biguanide, is also an effective antiseptic and disinfectant, 
that can trigger IgE-mediated type I hypersensitivity reactions in sensitized individuals (51). Many 
health care workers are exposed to hand washes containing chlorhexidine. In the United Kingdom, four 
cases of occupational IgE-mediated allergy to chlorhexidine were identified, the diagnosis being made 
on an appropriate clinical history with positive serum specific IgE to chlorhexidine and/or positive skin 
prick testing (52). 
 Interestingly, formaldehyde, described already in the previous NICoU section, is a primary skin 
sensitizer inducing allergic contact dermatitis also suspected to induce ICoU. There have been few 
reports on allergy to formaldehyde associated with IgE, and single cases of formaldehyde-specific IgE 
mediated urticaria exist in the literature (53). Thus, probably formaldehyde should be classified as a 
substance that shows mixed features of NICoU and ICoU, as the mechanism remains unclear. 
 
Drugs 
Antibiotics are very often associated to ICoU, such as penicillin (54). Allergic reactions are estimated 
to occur in approximately 2% of patients treated with penicillin. Most of these are maculopapular or 
urticarial rashes. Severe reactions to penicillin such as anaphylaxis can occur and are potentially life 
threatening. Penicillin belongs to the β-lactam group of antibiotics. All penicillin antibiotics contain a 
common nucleus (6-aminopenicillanic acid) composed of a β-lactam ring and a thiazolidine ring, this 
complex connected to a side chain. An intact β-lactam ring is necessary for bactericidal activity, and 
the side chain determines the spectrum of antibacterial activity, the susceptibility to destruction when 
exposed to acids and β-lactamases, and pharmacokinetics properties. Penicillin is a hapten and 
becomes immunogenic only when it binds to a protein. The β-lactam ring covalently binds to lysine 
residues of proteins and forms the penicilloyl group, known as the “major determinant” because it is 
the major penicillin metabolic product. Penicillin metabolites also form disulfide bonds with sulfhydryl 
groups of cysteine, producing the “minor determinants”, so called because they are formed in smaller 
quantities. Thus, immediate allergic reactions to penicillin are mediated through IgE antibodies against 
either the major or minor determinants or both. 
Based on this, penicillin skin testing techniques have been developed demonstrating the presence 
or absence of specific IgE antibodies against major and minor penicillin determinants. The use of 
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benzylpenicilloyl-poly-L-lysine can test IgE antibodies against major determinants. Histamine is used 
as a positive control, and saline is used as a negative control. Skin detection of serum IgE specific for 
major penicillin determinants has a high positive predictive value but fails to identify patients with 
penicillin allergy. It has been suggested that, ideally, skin testing to major and minor penicillin 
determinants would improve diagnosis. Methods of preparation of reagents for minor determinants 
have been published, and penicillin G has been used as a partial source of minor determinants. Today, 
alternatives to benzylpenicilloyl-poly-L-lysine and minor determinant mixtures are commercially 
available for skin testing (55). Penicillin skin testing is believed to be safe if done properly, although 
severe reactions such as anaphylaxis have been reported, these produced because violation of the test 
protocols such as doing intracutaneous testing without first doing prick testing. 
Concerning the RAST and the enzyme-linked immunosorbent assay (ELISA), they detect IgE 
antibodies to the major penicillin determinant only, with a sensitivity of approximately 80% (56). 
 The immunologic responses to different determinants of benzylpenicillin, amoxicillin and 
ampicillin have been also reported by using these methodologies (57). One study reported that the 
sensitization rate by skin prick and intradermal tests to benzylpenicilloyl-poly-L-lysine and a mixture 
of minor antigenic determinants was 12% in 83 asymptomatic Turkish nurses (58). Prick and 
intradermal penicillin sensitivity tests reported rates of 22% for benzylpenicilloyl-poly-L-lysine, 21% 
for minor determinant mixture, 43% for amoxicillin, and 33% for ampicillin in patients with a clinical 
history of urticaria and/or anaphylaxis (59). 
 After penicillins, cephalosporins are the most important β-lactams inducing IgE mediated 
reactions. Responses may be selective or cross-react with common β-lactam determinants. Unlike 
determinants derived from benzylpenicillin, cephalosporin allergenic determinants have not been well 
identified but it is possible to monitor serum specific IgEs. In a cross-reactivity study conducted with a 
group of Italian subjects who had immediate allergic reactions to one or more cephalosporins 
(ceftriaxone, cefotaxime, ceftazidime, cefuroxime), IgE evaluation was performed by skin tests and 
RASTs with the responsible drugs as well as to classic penicillin determinants (60). Prick and 
intradermal tests were performed with penicilloyl-polylysine, minor determinant mixture, penicillin G, 
ampicillin, amoxicillin, and with the cephalosporins. RAST used benzylpenicilloyl-polylysine, 
amoxicilloyl, ampicilloyl-polylysine and the cephalosporin conjugated to polylysine. The results 
suggested that a small percentage of cephalosporin allergic subjects reacted to penicillin determinants, 
and most had positive results to determinants generated only by cephalosporins. In a more recent study, 
the prevalence and risk factors of sensitization to cephalosporin was evaluated in a total of 161 health 
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care workers. The ELISA assay measured serum specific IgE antibodies to conjugates of three 
cephalosporins and HSA. Sensitization rates determined by this technique were 17.4% for any 
cephalosporin, 10.4% for cefotiam, 6.8% for ceftriaxone and 3.7% for ceftizoxime (61). 
 To mention other drugs involved in immediate skin reactions, a case of contact urticaria and 
anaphylaxis reaction following administration of powder containing clioquinol and bacitracin was 
described (62) and also immediate hypersensitivity reactions presumably IgE mediated to pyrazolones 
(63). 
 
Other chemicals 
 In plastic industry, workers are in contact with highly reacting chemicals. Cyclic acid anhydrides are 
synthetic highly reactive LMW compounds widely used as curing agents for epoxy resins and in the 
production of polyester resins. Commonly used anhydrides are phthalic anhydride, tetrahydrophthalic 
anhydride, methyl tetrahydrophthalic anhydride, hexahydrophthalic anhydride, methyl 
hexahydrophthalic anhydride, maleic anhydride and trimellitic anhydride. Cyclic acid anhydrides often 
cause allergic respiratory diseases, and in the literature only single case reports of contact urticaria of 
few patients were found. However, recently, occupational contact urticaria has been described by a 
Finnish study as workers may be exposed in powder or liquid form during manufacturing processes 
(64). Data are presented for 21 subjects who had been diagnosed with occupational contact urticaria 
because of exposure to organic acid anhydrides and examined during the period 1990-2006. Prick tests 
with HSA-acid anhydrides conjugates, RAST determination of specific IgE and open application tests 
were used for the diagnosis. The majority of the patients had been exposed to an epoxy resin containing 
methyl hexahydrophthalic anhydride. Specific IgE results were in line with the prick tests and the large 
reaction was seen for the acid anhydride the patient had been exposed to. Phthalic anhydride IgE was 
positive in 19 of 20 patients. Authors conclude that contact urticaria to these compounds may be more 
common than previously believed, as firstly shown by a previous Finnish study with two patients (65). 
 Another important constituent of epoxy resins that has been incriminated as producing immediate 
reactions is bisphenol A for which specific IgE were demonstrated to cause them (66). Similar studies 
have been reported for another known respiratory allergen, diphenylmethane-4,4’-diisocyanate (67, 
68), and for acrylates such as 2-ethylhexyl acrylate, acrylic acid, cyanoacrylates and methyl 
methacrylate (69). 
 Contact urticaria to permanent hair dyes such as para-phenylenediamine, which is a very well 
known skin sensitizer, is almost exclusively reported in consumers, but has also been described in a 
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beautician (70, 71). Other chemical compounds of LMW reported as inducing ICoU are aliphatic 
polyamides (72), methyl ethyl ketone, widely used as solvent in plastic manufacture (73) and 
monoamylamine (74) a vehicle ingredient of topical medicaments. 
 Finally, metals and metallic salts can also cause occupational contact urticaria. Aluminum (75), 
chromium, cobalt (76), iridium salts (77), nickel (75, 78), platinum salts and rhodium have been 
reported. Among them, platinum salts are important allergens in the catalyst industry and clinical 
manifestations may involve both the respiratory system and the skin (79, 80). In some cases, an 
immunological mechanism with specific IgE is demonstrated (78, 81). A RAST was developed for 
example for the measurement of IgE antibodies specific to platinum chloride complexes in sensitized 
workers (82). 
 
CONCLUSION 
Numerous LMW chemical compounds may cause contact urticaria, and many of these are encountered 
in everyday life. Skin clinical manifestations of immediate contact reactions can be expressed as 
urticaria and/or dermatitis. Both manifestations can be developed by the same patient and can be 
induced by the same compound simultaneously. Establishing a diagnosis of ICoU is therefore 
important, in order to confirm the need for allergen avoidance and in view of the potentially life 
threatening nature of this pathology. Substances responsible for immediate contact skin reactions may 
be classified by molecular weight, mechanism of action and occupational relevance. Cosmetics, plants, 
vegetables and food are still the most common agents responsible for new cases of contact urticaria. 
However, detailed chemical and biological studies continue to be necessary to determine the how and 
why, and the behavior that provide immunological signs.  
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Table 1. Chemical compounds reported as triggering immediate contact reactions and NICoU (1, 11) 
Fragrances-Cosmetics Biocides-Preservatives Drugs Other 
α-Amyl cinnamic aldehyde1 
Anisyl alcohol 
Balsam of Peru 
Benzaldehyde 
Benzophenone 
Cassia oil 
Cetyl alcohol (emulsifier)* 
Cinnamic acid 
Cinnamic alcohol1 
Cinnamic aldehyde1 
Cinnamon oil* 
Coumarin 
Eugenol1 
Geraniol1 
Hydroxycitronellal1 
Isoeugenol1 
Menthol 
Propylene glycol 
Pyrrolidone carboxylate 
Resorcinol 
Stearyl alcohol (emulsifier)* 
Vanillin 
Alcohols (amyl, ethyl, 
propyl, isopropyl, 
benzyl)* 
Benzoic acid 
Bronopol 
Camphor 
Chlorocresol 
Formaldehyde 
Imidazolidinyl urea 
Kathon CG 
2-Phenoxyethanol* 
Polyethyleneglycol* 
Sodium benzoate 
Sorbic acid 
Acetylsalicylic acid* 
Aminophenazone* 
Amoxicillin* 
Benzocain* 
Capsaicin 
Chlorpromazine* 
Dinitrochlorobenzene* 
Ketoprofen* 
Lidocaine* 
Nicotinic acid esters 
Pilocarpine* 
Propyphenazone* 
Promethazine* 
Steroids* 
Acetic acid*  
Butylhydroxytoluol* 
Chloroform 
Diethylfumarate* 
Dimethylammonium 
chloride* 
Dimethyl sulfoxide 
Fumaric acid* 
Panthenol* (hair product) 
Polypropylène* 
Trichloroethanol* 
Turpentine (plant derivative) 
Vinyl pyridine* 
Xylene* 
 
Metals 
Aluminum* 
Copper* 
Gold* 
Palladium* 
Rhodium 
Ruthenium 
Tin 
Zinc 
* Immediate contact reaction, unclassified non-immunological/immunological 
1 Constituent of the Fragrance Mix I 
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Table 2. Chemical compounds reported as triggering immunological immediate contact reactions/ICoU (1, 11) 
Fragrances-Cosmetics Biocides-Preservatives Drugs Other 
Allantoin1 
Polysorbates 
(emulsifier)1 
Sorbitan monolaurate 
(emulsifier)1 
Sorbitan monostearate 
(emulsifier)1 
Sorbitan sesquiolate 
(emulsifier)1 
Wool alcohol 
Ammonia 
Butylated-hydroxytoluene1 
Chloramine 
Chlorhexidine 
Chlorocresol 
Formaldehyde 
Mercurochrome 
Parabens1 
Phenyl mercuric acetate 
Phenyl mercuric 
propionate 
Sodium hypochlorite 
 
Aescin1 
Albendazole 
Ampicillin 
Azithromycin 
Bacitracin 
Benzoyl peroxide 
Cephalosporins 
Cisplatin 
Chloramphenicol 
Diphenylcyclopropenone 
Donezepil 
Gentamycin 
Iodochlorhydroxyquin 
Levopromazine 
Lindane 
Mechlorethamine 
Methamizole 
Mezlocillin 
Neomycin 
Penicillins 
Pentamidine isothionate 
Phenotiazides 
Pyrazolones 
Rifamycin 
Streptomycin 
Sulbactam 
Virginiamycin 
 
 
Acetyl acetone 
Acid anhydrides 
Acrylic acid1 
Acrylic monomers 
Aliphatic polyamide 
p-Aminodiphenylamine (dye)  
Aminothiazole1 
Aziridine 
Basic blue 99 (hair dye) 
Benzonitrile 
Bisphenol A 
Carbamates 
Chlorothalonil 
Colophony (plant derivative) 
Diethyltoluoamine 
Dibutylphthalate 
Di-(2-ethylhexyl) phthalate 
Diphenylmethane-4,4’-
diisocyanate 
Epoxy resins 
Formaldehyde resin 
Methyl ethyl ketone 
Monoamylamine 
Nylon 
p-Phenylenediamine (hair dye) 
 
Metals 
Chromium 
Cobalt 
Iridium 
Mercury1 
Nickel 
Platinum salts (Cisplatin) 
1 Described as (?) 
 
 
 
 
 
 
 
 
 
